Volume 1.07 | May 8

Intestinal Cell News 1.07 May 7, 2015
Intestinal Cell News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  ICN on Twitter
 
TOP STORY
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Scientists report the establishment of tumor organoid cultures from 20 consecutive colorectal carcinoma patients. For most, organoids were also generated from adjacent normal tissue. Organoids closely recapitulate several properties of the original tumor. [Cell] Abstract | Graphical Abstract
Request your FREE copy of STEMCELL Technologies' new 2015 catalog!
 
PUBLICATIONS (Ranked by impact factor of the journal)
INTESTINAL CANCERS & DISEASES

Reducing DNA Methylation Suppresses Colon Carcinogenesis by Inducing Tumor Cell Differentiation
Scientists found that a genome-wide reduction in the DNA methylation levels induced cellular differentiation in association with decreased cell proliferation in ApcMin/+ mouse colon tumor cells in vivo. [Carcinogenesis] Abstract

An Essential Role of cAMP Response Element-Binding Protein in Epidermal Growth Factor-Mediated Induction of Sodium/Glucose Cotransporter 1 Gene Expression and Intestinal Glucose Uptake
The authors demonstrated that CREB is involved in epidermal growth factor-mediated transcription regulation of the sodium/glucose cotransporter 1 gene in the normal and inflamed intestine. [Int J Biochem Cell Biol] Abstract

Downregulated Long Noncoding RNA BANCR Promotes the Proliferation of Colorectal Cancer Cells via Downregulation of p21 Expression
Researchers showed that BRAF activated non-coding RNA (BANCR) expression was significantly down-regulated in colorectal cancer tissues compared with normal tissues, and overexpression of BANCR suppressed colorectal cancer cell growth in vitro and in vivo. [PLoS One] Full Article

Commensal Streptococcus salivarius Modulates PPARγ Transcriptional Activity in Human Intestinal Epithelial Cells
Researchers used human intestinal epithelial cell lines engineered to monitor peroxisome proliferator-activated receptor (PPARγ) transcriptional activity in response to a wide range of S. salivarius strains. [PLoS One] Full Article

Altered Expression of Caspases-4 and -5 During Inflammatory Bowel Disease and Colorectal Cancer: Diagnostic and Therapeutic Potential
Scientists demonstrated that caspases-4 and -5 are involved in inflammatory bowel disease-associated intestinal inflammation. They also found robust expression of caspases-4 and -5 within intestinal epithelial cells, exclusively within neoplastic tissue, of colorectal tumours. [Clin Exp Immunol] Abstract

Short Hairpin RNA- Mediated Gene Knockdown of FOXM1 Inhibits the Proliferation and Metastasis of Human Colon Cancer Cells through Reversal of Epithelial-to-Mesenchymal Transformation
Investigators investigated FOXM1 protein expression in 87 colorectal cancer tissue specimens, invasive lymph nodes and adjacent paired normal colorectal tissues by immunohistochemical analysis. [J Exp Clin Cancer Res] Abstract

Mitogen-Activated Protein Kinase Phosphatase-1 Prevents Lipopolysaccharide-Induced Apoptosis in Immature Rat Intestinal Epithelial Cells
The authors demonstrated that mitogen-activated protein kinase phosphatase-1 has a central role in preventing inflammation-induced apoptosis in rIEC-6 enterocytes. [Pediatr Res] Abstract

INTESTINAL STEM CELL & ORGANOID RESEARCH

PERK Limits Drosophila Lifespan by Promoting Intestinal Stem Cell Proliferation in Response to ER Stress
The authors showed that the PKR-like ER kinase (PERK) integrates both cell-autonomous and non-autonomous endoplasmic reticulum (ER) stress stimuli to induce intestinal stem cell proliferation. [PLoS Genet] Full Article

Overlapping DNA Methylation Dynamics in Mouse Intestinal Cell Differentiation and Early Stages of Malignant Progression
Genome-scale analysis of DNA methylation together with microarray gene expression have been applied to compare intestinal crypt stem cells, differentiated cells, ApcMin/+ adenomas and the corresponding non-tumor adjacent tissue, together with small and large intestine samples and the colon cancer cell line CT26. [PLoS One] Full Article

Request a Sample: 3D Intestinal Organoid Culture Made Easy with IntestiCult™
 
REVIEWS
Intestinal Barrier Loss as a Critical Pathogenic Link Between Inflammatory Bowel Disease and Graft-Versus-Host Disease
The authors discuss similarities between inflammatory bowel disease and graft-versus-host disease, mechanisms of intestinal barrier loss in these diseases, and the crosstalk between barrier loss and the immune system. [Mucosal Immunol] Abstract

Visit our reviews page to see a complete list of reviews in the intestinal cell research field.
 
INDUSTRY NEWS
Lycera Initiates Phase I Clinical Trial of LYC-30937, a First-in-Class ATPase Modulator for Inflammatory Bowel Disease
Lycera Corp. announced the initiation of a Phase I clinical trial of LYC-30937 in healthy volunteers. LYC-30937 is designed to selectively induce cell death in disease-causing immune cells, sparing normal cells. [Lycera Corp.] Press Release

Generon Received US FDA Clearance to Initiate Phase IIa Study with F-652, a First-in-Class Biologic, to Treat Patients with Acute GvHD
Generon Corporation announced that it received US FDA clearance of the IND for a Phase IIa study, entitled “Recombinant Human Interleukin-22-IgG2-Fc (F-652) in Combination with Systemic Corticosteroids for the Treatment of Newly Diagnosed Grade II-IV Lower Gastrointestinal Acute Graft-versus-Host Disease (GvHD) in Hematopoietic Stem Cell Transplantation Recipients”. [Generon Corporation Ltd.] Press Release

From our sponsor: Studying ESCs or iPSCs? Request your free copy of the small molecules wallchart.
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW 2nd International Congress on Stem Cell and Cellular Therapies
October 15-18, 2015
Antalya, Turkey

NEW EMBL Conference: Cancer Genomics
November 1-4, 2015
Heidelberg, Germany

Visit our events page to see a complete list of events in the intestinal cell research community.
 
JOB OPPORTUNITIES
NEW Research Associate, Intestinal Cell Biology (STEMCELL Technologies Inc.)

NEW Postdoctoral Fellow – Principles of Cellular Processes (University of Southern California)

Scientist – Pluripotent Stem Cell Biology Endoderm Lineages (STEMCELL Technologies Inc.)

Assistant/Associate Professor – Cardiovascular and Lymphatic Biology (Texas A&M Health Science Center)

Postdoctoral Position – Genomics or Computational Genomics (Norwegian PSC research center)

Postdoctoral Fellow – Stem Cell Homeostasis in Gut Development and Disease (Sickkids Research Institute)

Postdoctoral Position – Physiology (Radboud University Nijmegen Medical Centre)

Postdoctoral Fellow – Transcriptional Mechanisms of Stomach and Intestinal Stem Cells (Sickkids Research Institute)

Postdoctoral Position – Functional Role of Intestinal Macrophages (University of Massachusetts Medical School)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Intestinal Cell News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Intestinal Cell News: Archives | Events | Contact Us